BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36998445)

  • 1.
    Vega JD; Hara D; Schmidt RM; Abuhaija MB; Tao W; Dogan N; Pollack A; Ford JC; Shi J
    Front Oncol; 2023; 13():1130155. PubMed ID: 36998445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical molecular imaging-guided radiation therapy part 2: Integrated x-ray and fluorescence molecular tomography.
    Shi J; Udayakumar TS; Wang Z; Dogan N; Pollack A; Yang Y
    Med Phys; 2017 Sep; 44(9):4795-4803. PubMed ID: 28626876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence background subtraction technique for hybrid fluorescence molecular tomography/x-ray computed tomography imaging of a mouse model of early stage lung cancer.
    Ale A; Ermolayev V; Deliolanis NC; Ntziachristos V
    J Biomed Opt; 2013 May; 18(5):56006. PubMed ID: 23640077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography-guided time-domain diffuse fluorescence tomography in small animals for localization of cancer biomarkers.
    Tichauer KM; Holt RW; Samkoe KS; El-Ghussein F; Gunn JR; Jermyn M; Dehghani H; Leblond F; Pogue BW
    J Vis Exp; 2012 Jul; (65):e4050. PubMed ID: 22847515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
    Tang C; Du Y; Liang Q; Cheng Z; Tian J
    Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multimodality Image Guided Precision Radiation Research Platform: Integrating X-ray, Bioluminescence, and Fluorescence Tomography With Radiation Therapy.
    Shi J; Xu K; Keyvanloo A; Udayakumar TS; Ahmad A; Yang F; Yang Y
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1063-1072. PubMed ID: 32585336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The feasibility of NaGdF
    Zhang W; Zhang S; Gao P; Lan B; Li L; Zhang X; Li L; Lu H
    Med Phys; 2020 Feb; 47(2):662-671. PubMed ID: 31742714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate Cancer Targeted X-Ray Fluorescence Imaging via Gold Nanoparticles Functionalized With Prostate-Specific Membrane Antigen (PSMA).
    Hara D; Tao W; Totiger TM; Pourmand A; Dogan N; Ford JC; Shi J; Pollack A
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):220-232. PubMed ID: 33964351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence Molecular Imaging and Tomography of Matrix Metalloproteinase-Activatable Near-Infrared Fluorescence Probe and Image-Guided Orthotopic Glioma Resection.
    Li L; Du Y; Chen X; Tian J
    Mol Imaging Biol; 2018 Dec; 20(6):930-939. PubMed ID: 29651576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/NIR-II fluorescence imaging and image-guided surgery of glioblastoma using a folate receptor α-targeted dual-modal nanoprobe.
    Shi X; Xu P; Cao C; Cheng Z; Tian J; Hu Z
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4325-4337. PubMed ID: 35838757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal subtraction contrast-enhanced dedicated breast CT.
    Gazi PM; Aminololama-Shakeri S; Yang K; Boone JM
    Phys Med Biol; 2016 Sep; 61(17):6322-46. PubMed ID: 27494376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial glioma xenograft model rapidly reestablishes blood-brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents.
    Habimana-Griffin L; Ye D; Carpenter J; Prior J; Sudlow G; Marsala L; Mixdorf M; Rubin J; Chen H; Achilefu S
    J Biomed Opt; 2020 Feb; 25(2):1-13. PubMed ID: 32112540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors.
    Adumeau L; Genevois C; Roudier L; Schatz C; Couillaud F; Mornet S
    Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1587-1596. PubMed ID: 28179102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting.
    Pérez-Medina C; Abdel-Atti D; Zhang Y; Longo VA; Irwin CP; Binderup T; Ruiz-Cabello J; Fayad ZA; Lewis JS; Mulder WJ; Reiner T
    J Nucl Med; 2014 Oct; 55(10):1706-11. PubMed ID: 25060196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo tumor-targeted dual-modal fluorescence/CT imaging using a nanoprobe co-loaded with an aggregation-induced emission dye and gold nanoparticles.
    Zhang J; Li C; Zhang X; Huo S; Jin S; An FF; Wang X; Xue X; Okeke CI; Duan G; Guo F; Zhang X; Hao J; Wang PC; Zhang J; Liang XJ
    Biomaterials; 2015 Feb; 42():103-11. PubMed ID: 25542798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-targeting CuS nanoparticles for multimodal imaging and guided photothermal therapy of lymph node metastasis.
    Shi H; Yan R; Wu L; Sun Y; Liu S; Zhou Z; He J; Ye D
    Acta Biomater; 2018 May; 72():256-265. PubMed ID: 29588255
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.